Allurion Technologies Inc. (ALUR) 是一家上市公司 属于 医疗保健 板块,经营于 Medical - Devices 行业. 公司总部位于 Natick, MA, 美国. 现任CEO为 Samuel G. Levy.
ALUR 拥有 IPO日期为 2021-03-29, 134 名全职员工, 在 Other OTC, 市值为 $6.79M.
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.